95 related articles for article (PubMed ID: 1698796)
1. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a neuropeptide antagonist, blocks binding, Ca2(+)-mobilizing, and mitogenic effects of endothelin and vasoactive intestinal contractor in mouse 3T3 cells.
Fabregat I; Rozengurt E
J Cell Physiol; 1990 Oct; 145(1):88-94. PubMed ID: 1698796
[TBL] [Abstract][Full Text] [Related]
2. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.
Woll PJ; Rozengurt E
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1859-63. PubMed ID: 2450349
[TBL] [Abstract][Full Text] [Related]
3. [D-Arg1,D-Trp5,7,9,Leu11]Substance P coordinately and reversibly inhibits bombesin- and vasopressin-induced signal transduction pathways in Swiss 3T3 cells.
Seckl MJ; Higgins T; Rozengurt E
J Biol Chem; 1996 Nov; 271(46):29453-60. PubMed ID: 8910612
[TBL] [Abstract][Full Text] [Related]
4. [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P induces apoptosis in lung cancer cell lines in vitro.
Reeve JG; Bleehen NM
Biochem Biophys Res Commun; 1994 Mar; 199(3):1313-9. PubMed ID: 7511895
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of calcium mobilization but not proliferation by bombesin and tachykinin neuropeptides in human small cell lung cancer cells.
Takuwa N; Takuwa Y; Ohue Y; Mukai H; Endoh K; Yamashita K; Kumada M; Munekata E
Cancer Res; 1990 Jan; 50(2):240-4. PubMed ID: 1688510
[TBL] [Abstract][Full Text] [Related]
6. A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro.
Woll PJ; Rozengurt E
Cancer Res; 1990 Jul; 50(13):3968-73. PubMed ID: 1693879
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2-independent induction of apoptosis by neuropeptide receptor antagonist in human small cell lung carcinoma cells.
Matsumoto Y; Kawatani M; Simizu S; Tanaka T; Takada M; Imoto M
Anticancer Res; 2000; 20(5A):3123-9. PubMed ID: 11062732
[TBL] [Abstract][Full Text] [Related]
8. A substance P antagonist also inhibits specific binding and mitogenic effects of vasopressin and bombesin-related peptides in Swiss 3T3 cells.
Zachary I; Rozengurt E
Biochem Biophys Res Commun; 1986 May; 137(1):135-41. PubMed ID: 2424443
[TBL] [Abstract][Full Text] [Related]
9. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
Rozengurt E; Sinnett-Smith JW
J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation of bombesin-stimulated phospholipase C beta and mitogen-activated protein kinase activity by [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P.
Mitchell FM; Heasley LE; Qian NX; Zamarripa J; Johnson GL
J Biol Chem; 1995 Apr; 270(15):8623-8. PubMed ID: 7536738
[TBL] [Abstract][Full Text] [Related]
11. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]Substance P acts as a biased agonist toward neuropeptide and chemokine receptors.
Jarpe MB; Knall C; Mitchell FM; Buhl AM; Duzic E; Johnson GL
J Biol Chem; 1998 Jan; 273(5):3097-104. PubMed ID: 9446627
[TBL] [Abstract][Full Text] [Related]
12. Gastrin stimulates Ca2+ mobilization and clonal growth in small cell lung cancer cells.
Sethi T; Rozengurt E
Cancer Res; 1992 Nov; 52(21):6031-5. PubMed ID: 1327522
[TBL] [Abstract][Full Text] [Related]
13. Solution conformation of Substance P antagonists-[D-Arg1, D-Trp7,9, Leu11]-SP, [D-Arg1, D-Pro2, D-Trp7,9, Leu11]-SP and [D-Pro2, D-Trp7,9]-SP by CD, NMR and MD simulations.
Prabhu A; Malde A; Coutinho E; Srivastava S
Peptides; 2005 May; 26(5):875-85. PubMed ID: 15808918
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal contractor, a novel peptide, shares a common receptor with endothelin-1 and stimulates Ca2+ mobilization and DNA synthesis in Swiss 3T3 cells.
Fabregat I; Rozengurt E
Biochem Biophys Res Commun; 1990 Feb; 167(1):161-7. PubMed ID: 2155611
[TBL] [Abstract][Full Text] [Related]
15. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
Narayan S; Guo YS; Townsend CM; Singh P
Cancer Res; 1990 Nov; 50(21):6772-8. PubMed ID: 2208141
[TBL] [Abstract][Full Text] [Related]
16. Substance P-related antagonists inhibit vasopressin and bombesin but not 5'-3-O-(thio)triphosphate-stimulated inositol phosphate production in Swiss 3T3 cells.
Seckl MJ; Newman RH; Freemont PS; Rozengurt E
J Cell Physiol; 1995 Apr; 163(1):87-95. PubMed ID: 7534771
[TBL] [Abstract][Full Text] [Related]
17. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo.
Langdon S; Sethi T; Ritchie A; Muir M; Smyth J; Rozengurt E
Cancer Res; 1992 Aug; 52(16):4554-7. PubMed ID: 1379515
[TBL] [Abstract][Full Text] [Related]
18. [D-Arg1,D-Trp5,7,9,Leu11]substance P: a novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells.
Seckl MJ; Higgins T; Widmer F; Rozengurt E
Cancer Res; 1997 Jan; 57(1):51-4. PubMed ID: 8988040
[TBL] [Abstract][Full Text] [Related]
19. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P.
Jones DA; Cummings J; Langdon SP; Maclellan AJ; Higgins T; Rozengurt E; Smyth JF
Br J Cancer; 1996 Mar; 73(6):715-20. PubMed ID: 8611370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
